Click for best price
Adipose Derived Stem Cell Therapy Market Size, Share 2023
Adipose tissue stem cells (ASCs), known as multipotent stem cells, are most commonly used in the clinical applications in recent years.
This report aims to provide a comprehensive presentation of the global market for Adipose Derived Stem Cell Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Adipose Derived Stem Cell Therapy. This report contains market size and forecasts of Adipose Derived Stem Cell Therapy in global, including the following market information:
Global Adipose Derived Stem Cell Therapy Market Revenue, 2018-2023, 2024-2030, ($ millions)
Global top five companies in 2022 (%)
The global Adipose Derived Stem Cell Therapy market was valued at US$ million in 2022 and is projected to reach US$ million by 2029, at a CAGR of % during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
The U.S. Market is Estimated at $ Million in 2022, While China is to reach $ Million.
Autologous Stem Cells Segment to Reach $ Million by 2029, with a % CAGR in next six years.
The global key manufacturers of Adipose Derived Stem Cell Therapy include AlloCure, Antria, Celgene Corporation, Cellleris, Corestem, Cytori Therapeutics, Intrexon, Mesoblast and Pluristem Therapeutics, etc. in 2022, the global top five players have a share approximately % in terms of revenue.
We surveyed the Adipose Derived Stem Cell Therapy companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Adipose Derived Stem Cell Therapy Market, by Type, 2018-2023, 2024-2030 ($ millions)
Global Adipose Derived Stem Cell Therapy Market Segment Percentages, by Type, 2022 (%)
Autologous Stem Cells
Allogeneic Stem Cells
Global Adipose Derived Stem Cell Therapy Market, by Application, 2018-2023, 2024-2030 ($ millions)
Global Adipose Derived Stem Cell Therapy Market Segment Percentages, by Application, 2022 (%)
Therapeutic Application
Research Application
Global Adipose Derived Stem Cell Therapy Market, By Region and Country, 2018-2023, 2024-2030 ($ Millions)
Global Adipose Derived Stem Cell Therapy Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Adipose Derived Stem Cell Therapy revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Adipose Derived Stem Cell Therapy revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
AlloCure
Antria
Celgene Corporation
Cellleris
Corestem
Cytori Therapeutics
Intrexon
Mesoblast
Pluristem Therapeutics
Tissue Genesis
BioRestorative Therapies
Celltex Therapeutics Corporation
iXCells Biotechnologies
Pluristem Therapeutics
Cyagen
Lonza
Outline of Major Chapters:
Chapter 1: Introduces the definition of Adipose Derived Stem Cell Therapy, market overview.
Chapter 2: Global Adipose Derived Stem Cell Therapy market size in revenue.
Chapter 3: Detailed analysis of Adipose Derived Stem Cell Therapy company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Adipose Derived Stem Cell Therapy in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Adipose Derived Stem Cell Therapy Market, Global Outlook and Forecast 2023-2030 |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
102 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Adipose Derived Stem Cell Therapy Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Adipose Derived Stem Cell Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Adipose Derived Stem Cell Therapy Overall Market Size
2.1 Global Adipose Derived Stem Cell Therapy Market Size: 2022 VS 2030
2.2 Global Adipose Derived Stem Cell Therapy Market Size, Prospects & Forecasts: 2018-2030
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Adipose Derived Stem Cell Therapy Players in Global Market
3.2 Top Global Adipose Derived Stem Cell Therapy Companies Ranked by Revenue
3.3 Global Adipose Derived Stem Cell Therapy Revenue by Companies
3.4 Top 3 and Top 5 Adipose Derived Stem Cell Therapy Companies in Global Market, by Revenue in 2022
3.5 Global Companies Adipose Derived Stem Cell Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Adipose Derived Stem Cell Therapy Players in Global Market
3.6.1 List of Global Tier 1 Adipose Derived Stem Cell Therapy Companies
3.6.2 List of Global Tier 2 and Tier 3 Adipose Derived Stem Cell Therapy Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Adipose Derived Stem Cell Therapy Market Size Markets, 2022 & 2030
4.1.2 Autologous Stem Cells
4.1.3 Allogeneic Stem Cells
4.2 By Type - Global Adipose Derived Stem Cell Therapy Revenue & Forecasts
4.2.1 By Type - Global Adipose Derived Stem Cell Therapy Revenue, 2018-2023
4.2.2 By Type - Global Adipose Derived Stem Cell Therapy Revenue, 2024-2030
4.2.3 By Type - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Adipose Derived Stem Cell Therapy Market Size, 2022 & 2030
5.1.2 Therapeutic Application
5.1.3 Research Application
5.2 By Application - Global Adipose Derived Stem Cell Therapy Revenue & Forecasts
5.2.1 By Application - Global Adipose Derived Stem Cell Therapy Revenue, 2018-2023
5.2.2 By Application - Global Adipose Derived Stem Cell Therapy Revenue, 2024-2030
5.2.3 By Application - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
6 Sights by Region
6.1 By Region - Global Adipose Derived Stem Cell Therapy Market Size, 2022 & 2030
6.2 By Region - Global Adipose Derived Stem Cell Therapy Revenue & Forecasts
6.2.1 By Region - Global Adipose Derived Stem Cell Therapy Revenue, 2018-2023
6.2.2 By Region - Global Adipose Derived Stem Cell Therapy Revenue, 2024-2030
6.2.3 By Region - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
6.3 North America
6.3.1 By Country - North America Adipose Derived Stem Cell Therapy Revenue, 2018-2030
6.3.2 US Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.3.3 Canada Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.3.4 Mexico Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4 Europe
6.4.1 By Country - Europe Adipose Derived Stem Cell Therapy Revenue, 2018-2030
6.4.2 Germany Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4.3 France Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4.4 U.K. Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4.5 Italy Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4.6 Russia Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4.7 Nordic Countries Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.4.8 Benelux Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.5 Asia
6.5.1 By Region - Asia Adipose Derived Stem Cell Therapy Revenue, 2018-2030
6.5.2 China Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.5.3 Japan Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.5.4 South Korea Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.5.5 Southeast Asia Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.5.6 India Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.6 South America
6.6.1 By Country - South America Adipose Derived Stem Cell Therapy Revenue, 2018-2030
6.6.2 Brazil Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.6.3 Argentina Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Adipose Derived Stem Cell Therapy Revenue, 2018-2030
6.7.2 Turkey Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.7.3 Israel Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.7.4 Saudi Arabia Adipose Derived Stem Cell Therapy Market Size, 2018-2030
6.7.5 UAE Adipose Derived Stem Cell Therapy Market Size, 2018-2030
7 Adipose Derived Stem Cell Therapy Companies Profiles
7.1 AlloCure
7.1.1 AlloCure Company Summary
7.1.2 AlloCure Business Overview
7.1.3 AlloCure Adipose Derived Stem Cell Therapy Major Product Offerings
7.1.4 AlloCure Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.1.5 AlloCure Key News & Latest Developments
7.2 Antria
7.2.1 Antria Company Summary
7.2.2 Antria Business Overview
7.2.3 Antria Adipose Derived Stem Cell Therapy Major Product Offerings
7.2.4 Antria Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.2.5 Antria Key News & Latest Developments
7.3 Celgene Corporation
7.3.1 Celgene Corporation Company Summary
7.3.2 Celgene Corporation Business Overview
7.3.3 Celgene Corporation Adipose Derived Stem Cell Therapy Major Product Offerings
7.3.4 Celgene Corporation Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.3.5 Celgene Corporation Key News & Latest Developments
7.4 Cellleris
7.4.1 Cellleris Company Summary
7.4.2 Cellleris Business Overview
7.4.3 Cellleris Adipose Derived Stem Cell Therapy Major Product Offerings
7.4.4 Cellleris Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.4.5 Cellleris Key News & Latest Developments
7.5 Corestem
7.5.1 Corestem Company Summary
7.5.2 Corestem Business Overview
7.5.3 Corestem Adipose Derived Stem Cell Therapy Major Product Offerings
7.5.4 Corestem Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.5.5 Corestem Key News & Latest Developments
7.6 Cytori Therapeutics
7.6.1 Cytori Therapeutics Company Summary
7.6.2 Cytori Therapeutics Business Overview
7.6.3 Cytori Therapeutics Adipose Derived Stem Cell Therapy Major Product Offerings
7.6.4 Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.6.5 Cytori Therapeutics Key News & Latest Developments
7.7 Intrexon
7.7.1 Intrexon Company Summary
7.7.2 Intrexon Business Overview
7.7.3 Intrexon Adipose Derived Stem Cell Therapy Major Product Offerings
7.7.4 Intrexon Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.7.5 Intrexon Key News & Latest Developments
7.8 Mesoblast
7.8.1 Mesoblast Company Summary
7.8.2 Mesoblast Business Overview
7.8.3 Mesoblast Adipose Derived Stem Cell Therapy Major Product Offerings
7.8.4 Mesoblast Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.8.5 Mesoblast Key News & Latest Developments
7.9 Pluristem Therapeutics
7.9.1 Pluristem Therapeutics Company Summary
7.9.2 Pluristem Therapeutics Business Overview
7.9.3 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Major Product Offerings
7.9.4 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.9.5 Pluristem Therapeutics Key News & Latest Developments
7.10 Tissue Genesis
7.10.1 Tissue Genesis Company Summary
7.10.2 Tissue Genesis Business Overview
7.10.3 Tissue Genesis Adipose Derived Stem Cell Therapy Major Product Offerings
7.10.4 Tissue Genesis Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.10.5 Tissue Genesis Key News & Latest Developments
7.11 BioRestorative Therapies
7.11.1 BioRestorative Therapies Company Summary
7.11.2 BioRestorative Therapies Business Overview
7.11.3 BioRestorative Therapies Adipose Derived Stem Cell Therapy Major Product Offerings
7.11.4 BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.11.5 BioRestorative Therapies Key News & Latest Developments
7.12 Celltex Therapeutics Corporation
7.12.1 Celltex Therapeutics Corporation Company Summary
7.12.2 Celltex Therapeutics Corporation Business Overview
7.12.3 Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Major Product Offerings
7.12.4 Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.12.5 Celltex Therapeutics Corporation Key News & Latest Developments
7.13 iXCells Biotechnologies
7.13.1 iXCells Biotechnologies Company Summary
7.13.2 iXCells Biotechnologies Business Overview
7.13.3 iXCells Biotechnologies Adipose Derived Stem Cell Therapy Major Product Offerings
7.13.4 iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.13.5 iXCells Biotechnologies Key News & Latest Developments
7.14 Pluristem Therapeutics
7.14.1 Pluristem Therapeutics Company Summary
7.14.2 Pluristem Therapeutics Business Overview
7.14.3 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Major Product Offerings
7.14.4 Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.14.5 Pluristem Therapeutics Key News & Latest Developments
7.15 Cyagen
7.15.1 Cyagen Company Summary
7.15.2 Cyagen Business Overview
7.15.3 Cyagen Adipose Derived Stem Cell Therapy Major Product Offerings
7.15.4 Cyagen Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.15.5 Cyagen Key News & Latest Developments
7.16 Lonza
7.16.1 Lonza Company Summary
7.16.2 Lonza Business Overview
7.16.3 Lonza Adipose Derived Stem Cell Therapy Major Product Offerings
7.16.4 Lonza Adipose Derived Stem Cell Therapy Revenue in Global Market (2018-2023)
7.16.5 Lonza Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Adipose Derived Stem Cell Therapy Market Opportunities & Trends in Global Market
Table 2. Adipose Derived Stem Cell Therapy Market Drivers in Global Market
Table 3. Adipose Derived Stem Cell Therapy Market Restraints in Global Market
Table 4. Key Players of Adipose Derived Stem Cell Therapy in Global Market
Table 5. Top Adipose Derived Stem Cell Therapy Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Adipose Derived Stem Cell Therapy Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Adipose Derived Stem Cell Therapy Revenue Share by Companies, 2018-2023
Table 8. Global Companies Adipose Derived Stem Cell Therapy Product Type
Table 9. List of Global Tier 1 Adipose Derived Stem Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Adipose Derived Stem Cell Therapy Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 12. By Type - Adipose Derived Stem Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Adipose Derived Stem Cell Therapy Revenue in Global (US$, Mn), 2024-2030
Table 14. By Application ? Global Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 15. By Application - Adipose Derived Stem Cell Therapy Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Adipose Derived Stem Cell Therapy Revenue in Global (US$, Mn), 2024-2030
Table 17. By Region ? Global Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Table 18. By Region - Global Adipose Derived Stem Cell Therapy Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Adipose Derived Stem Cell Therapy Revenue (US$, Mn), 2024-2030
Table 20. By Country - North America Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 22. By Country - Europe Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 24. By Region - Asia Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 26. By Country - South America Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 28. By Country - Middle East & Africa Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2024-2030
Table 30. AlloCure Company Summary
Table 31. AlloCure Adipose Derived Stem Cell Therapy Product Offerings
Table 32. AlloCure Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 33. AlloCure Key News & Latest Developments
Table 34. Antria Company Summary
Table 35. Antria Adipose Derived Stem Cell Therapy Product Offerings
Table 36. Antria Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 37. Antria Key News & Latest Developments
Table 38. Celgene Corporation Company Summary
Table 39. Celgene Corporation Adipose Derived Stem Cell Therapy Product Offerings
Table 40. Celgene Corporation Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 41. Celgene Corporation Key News & Latest Developments
Table 42. Cellleris Company Summary
Table 43. Cellleris Adipose Derived Stem Cell Therapy Product Offerings
Table 44. Cellleris Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 45. Cellleris Key News & Latest Developments
Table 46. Corestem Company Summary
Table 47. Corestem Adipose Derived Stem Cell Therapy Product Offerings
Table 48. Corestem Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 49. Corestem Key News & Latest Developments
Table 50. Cytori Therapeutics Company Summary
Table 51. Cytori Therapeutics Adipose Derived Stem Cell Therapy Product Offerings
Table 52. Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 53. Cytori Therapeutics Key News & Latest Developments
Table 54. Intrexon Company Summary
Table 55. Intrexon Adipose Derived Stem Cell Therapy Product Offerings
Table 56. Intrexon Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 57. Intrexon Key News & Latest Developments
Table 58. Mesoblast Company Summary
Table 59. Mesoblast Adipose Derived Stem Cell Therapy Product Offerings
Table 60. Mesoblast Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 61. Mesoblast Key News & Latest Developments
Table 62. Pluristem Therapeutics Company Summary
Table 63. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product Offerings
Table 64. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 65. Pluristem Therapeutics Key News & Latest Developments
Table 66. Tissue Genesis Company Summary
Table 67. Tissue Genesis Adipose Derived Stem Cell Therapy Product Offerings
Table 68. Tissue Genesis Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 69. Tissue Genesis Key News & Latest Developments
Table 70. BioRestorative Therapies Company Summary
Table 71. BioRestorative Therapies Adipose Derived Stem Cell Therapy Product Offerings
Table 72. BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 73. BioRestorative Therapies Key News & Latest Developments
Table 74. Celltex Therapeutics Corporation Company Summary
Table 75. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Product Offerings
Table 76. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 77. Celltex Therapeutics Corporation Key News & Latest Developments
Table 78. iXCells Biotechnologies Company Summary
Table 79. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Product Offerings
Table 80. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 81. iXCells Biotechnologies Key News & Latest Developments
Table 82. Pluristem Therapeutics Company Summary
Table 83. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Product Offerings
Table 84. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 85. Pluristem Therapeutics Key News & Latest Developments
Table 86. Cyagen Company Summary
Table 87. Cyagen Adipose Derived Stem Cell Therapy Product Offerings
Table 88. Cyagen Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 89. Cyagen Key News & Latest Developments
Table 90. Lonza Company Summary
Table 91. Lonza Adipose Derived Stem Cell Therapy Product Offerings
Table 92. Lonza Adipose Derived Stem Cell Therapy Revenue (US$, Mn) & (2018-2023)
Table 93. Lonza Key News & Latest Developments
List of Figures
Figure 1. Adipose Derived Stem Cell Therapy Segment by Type in 2022
Figure 2. Adipose Derived Stem Cell Therapy Segment by Application in 2022
Figure 3. Global Adipose Derived Stem Cell Therapy Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Adipose Derived Stem Cell Therapy Market Size: 2022 VS 2030 (US$, Mn)
Figure 6. Global Adipose Derived Stem Cell Therapy Revenue, 2018-2030 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Adipose Derived Stem Cell Therapy Revenue in 2022
Figure 8. By Type - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 9. By Application - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 10. By Type - Global Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 11. By Type - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 12. By Application - Global Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2022 & 2030
Figure 13. By Application - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 14. By Region - Global Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 15. By Country - North America Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 16. US Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 17. Canada Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 18. Mexico Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 19. By Country - Europe Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 20. Germany Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 21. France Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 22. U.K. Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 23. Italy Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 24. Russia Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 25. Nordic Countries Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 26. Benelux Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 27. By Region - Asia Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 28. China Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 29. Japan Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 30. South Korea Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 31. Southeast Asia Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 32. India Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 33. By Country - South America Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 34. Brazil Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 35. Argentina Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 36. By Country - Middle East & Africa Adipose Derived Stem Cell Therapy Revenue Market Share, 2018-2030
Figure 37. Turkey Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 38. Israel Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 39. Saudi Arabia Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 40. UAE Adipose Derived Stem Cell Therapy Revenue, (US$, Mn), 2018-2030
Figure 41. AlloCure Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Antria Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Celgene Corporation Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Cellleris Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Corestem Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Cytori Therapeutics Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Intrexon Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Mesoblast Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. Tissue Genesis Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 51. BioRestorative Therapies Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 52. Celltex Therapeutics Corporation Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 53. iXCells Biotechnologies Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 54. Pluristem Therapeutics Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 55. Cyagen Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 56. Lonza Adipose Derived Stem Cell Therapy Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
